Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Atai Life Sciences N.V. (ATAI)

Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 222,650
  • Shares Outstanding, K 167,406
  • Annual Sales, $ 310 K
  • Annual Income, $ -40,220 K
  • 60-Month Beta 0.83
  • Price/Sales 703.74
  • Price/Cash Flow N/A
  • Price/Book 0.99
Trade ATAI with:

Options Overview Details

View History
  • Implied Volatility 78.27% ( -47.10%)
  • Historical Volatility 64.68%
  • IV Percentile 13%
  • IV Rank 4.82%
  • IV High 817.27% on 10/25/23
  • IV Low 40.85% on 05/13/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 61
  • Volume Avg (30-Day) 167
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 10,867
  • Open Int (30-Day) 11,832

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.17
  • Number of Estimates 3
  • High Estimate -0.16
  • Low Estimate -0.19
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 +6.40%
on 06/20/24
1.7200 -22.67%
on 05/30/24
-0.3300 (-19.88%)
since 05/28/24
3-Month
1.2500 +6.40%
on 06/20/24
2.8500 -53.33%
on 04/04/24
-0.6400 (-32.49%)
since 03/28/24
52-Week
1.0250 +29.76%
on 12/01/23
2.8500 -53.33%
on 04/04/24
-0.3100 (-18.90%)
since 06/28/23

Most Recent Stories

More News
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 146.16 (+0.25%)
CMPS : 6.04 (+0.83%)
MNMD : 7.21 (-0.55%)
ATAI : 1.3300 (+0.76%)
ABBV : 171.52 (+1.50%)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

CMPS : 6.04 (+0.83%)
SEEL : 0.5970 (-2.10%)
ATAI : 1.3300 (+0.76%)
MNMD : 7.21 (-0.55%)
NUMI.TO : 0.0450 (unch)
NUMIF : 0.0325 (+0.31%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

CMPS : 6.04 (+0.83%)
SEEL : 0.5970 (-2.10%)
ATAI : 1.3300 (+0.76%)
MNMD : 7.21 (-0.55%)
NUMI.TO : 0.0450 (unch)
NUMIF : 0.0325 (+0.31%)
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END

CYBN.NE : 0.3700 (+4.23%)
MMED.NE : 14.9000 (+9.48%)
CYBN : 0.2710 (+2.46%)
ATAI : 1.3300 (+0.76%)
MNMD : 7.21 (-0.55%)
SEEL : 0.5970 (-2.10%)
CMPS : 6.04 (+0.83%)
3 Big New Catalysts for Psychedelics Stocks in 2024

This could be the year that psychedelics stocks start to fly.

CMPS : 6.04 (+0.83%)
ATAI : 1.3300 (+0.76%)
ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT

/CNW/ - This press release is being issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting...

ATAI : 1.3300 (+0.76%)
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis

EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END

ABBV : 171.52 (+1.50%)
ATAI : 1.3300 (+0.76%)
CMPS : 6.04 (+0.83%)
MNMD : 7.21 (-0.55%)
JNJ : 146.16 (+0.25%)
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?

Atai's stock is hurting, but its pipeline is still packed with promising programs.

CMPS : 6.04 (+0.83%)
ATAI : 1.3300 (+0.76%)
Why Shares of Atai Life Sciences Rose Friday

The company's co-founder and chairman increased his position and explained why.

ATAI : 1.3300 (+0.76%)
Why Atai Life Sciences Stock Stormed Higher This Week

The biotech's strong financial position may be attracting bargain buyers right now.

ATAI : 1.3300 (+0.76%)

Business Summary

atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.

See More

Key Turning Points

3rd Resistance Point 1.4867
2nd Resistance Point 1.4433
1st Resistance Point 1.3867
Last Price 1.3300
1st Support Level 1.2867
2nd Support Level 1.2433
3rd Support Level 1.1867

See More

52-Week High 2.8500
Fibonacci 61.8% 2.1528
Fibonacci 50% 1.9375
Fibonacci 38.2% 1.7221
Last Price 1.3300
52-Week Low 1.0250

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar